Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China
1 other identifier
observational
300
1 country
1
Brief Summary
to investigate the prevalence of hepatopulmonary syndrome in cirrhosis patients caused by Hepatitis B in western China
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 27, 2017
CompletedFirst Submitted
Initial submission to the registry
February 2, 2018
CompletedFirst Posted
Study publicly available on registry
February 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedFebruary 19, 2018
February 1, 2018
8 months
February 2, 2018
February 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
transthoracic contrast enhanced echocardiography (CEE)
through the ultrasound to evaluate the imagine of cardiac cavity after intravenous injection of agitated saline
During the operation
arterial blood gas
arterial blood gas analysis was performed through the radial artery.
During the operation
medical history
The medical history was collected through consultation.
During the operation
acropachy
acropachy was examined by inspection
During the operation
spider angioma
spider angioma was examined by inspection
During the operation
liver palms
liver palms was examined by inspection
During the operation
oxygen saturation
oxygen saturation was examined by pulse oximetry
During the operation
Secondary Outcomes (2)
the content of bone morphogenetic protein (BMP9) in the patients with and without HPS
4 to 6 months after the study completion
micro ribonucleic acid 144 (miR144), micro ribonucleic acid 200 (miR200) in the patients with and without HPS
4 to 6 months after the study completion
Study Arms (2)
cirrhosis with HPS
Diagnosed as HPS
cirrhosis without HPS
Not Diagnosed as HPS
Eligibility Criteria
Patients were selected with cirrhosis caused by HBV including Southwest Hospital, the first affiliated hospital of Chongqing Medical University, the People's hospital of Rongchang district and Qijiang District people's hospital
You may qualify if:
- Age: 18-80 years old;
- American association of anesthesiologists(ASA) score: I-III;
- Ability to comply with research programmes;
- Voluntary participation in the study;
- Has the history of HBV infection;
- No primary cardiopulmonary disease (heart disease, emphysema, pneumonia, asthma, etc.)
You may not qualify if:
- Severe heart, lung, kidney disease coexisted;
- American association of anesthesiologists(ASA) score≥IV; forced expiratory volume at one second (FEV1) or forced vital capacity (FVC) \<70%, or FEV1 / FVC \<0.70;
- Mental state could not cooperate
- Absence of written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology, Southwest Hospital Third Military Medical University
Chongqing, Chongqing Municipality, 400038, China
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lu K Zhi, PhD
Department of Anesthesiology, Southwest Hospital Third Military Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Institute of Anesthesiology, Southwest Hospital, Third Military Medical University Affiliation: Southwest Hospital, China
Study Record Dates
First Submitted
February 2, 2018
First Posted
February 19, 2018
Study Start
July 27, 2017
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
February 19, 2018
Record last verified: 2018-02